Martis Capital Management, LLC, a San Francisco, CA and Washington, DC-based healthcare-focused private equity firm, closed its fourth fund and largest to date, Martis Partners IV, LP, at $779 million. 

The firm launched the fund in 2022 targeting $700 million with a hard cap of $750 million. With the new fund, the firm has raised more than $2.1 billion in capital to date. 

Martis Capital has made three investments from Fund IV in companies specializing in clinical research trials, value-based primary care and dental care, including Rise Health and Alcanza Clinical Research, which it purchased in October. 

“Fund IV, our largest to date, is off to a great start. Our three initial investments are performing well, a testament to the quality of our partner companies and the research and due diligence of the Martis Capital team,” said Owen Davis, managing partner. 

Previously known as Capricorn Healthcare, the firm closed its third fund at $550 million in 2018 and raised a combined $600 million for its inaugural and sophomore fund. 

Martis Capital invests in buyout and growth equity opportunities in middle-market companies within the services and outsourcing, IT and consumer and wellness subsectors of the healthcare industry. 

Don’t miss the Connect Money: Alternative Assets Conference on June 14 in Chicago at the W City Center. Connect in person with industry experts like Glenn Spencer, CEO Prime Capital Investment Advisors.